CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 20 8089 7893 support@capital.com

Trade Recordati SPA - RECm CFD

40.65
0.27%
0.15
Low: 40.06
High: 40.67
Market Trading Hours* (UTC) Opens on Monday at 08:01

Mon - Fri: 08:01 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.15
Long position overnight fee

Long position overnight fee

Margin. Your investment $1,000.00
Overnight fee -0.024161 %
Charges from borrowed part ($-0.97)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Go to platform
-0.024161%
Short position overnight fee

Short position overnight fee

Margin. Your investment $1,000.00
Overnight fee -0.020283 %
Charges from borrowed part ($-0.81)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Go to platform
-0.020283%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 20%
Stock exchange Italy
Commission on trade 0%

*Information provided by Capital.com

Recordati Industria Chimica e Farmaceutica SpA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 40.54
Open* 40.34
1-Year Change* -18.32%
Day's Range* 40.06 - 40.67
52 wk Range 34.52-50.50
Average Volume (10 days) 166.81K
Average Volume (3 months) 4.37M
Market Cap 8.52B
P/E Ratio 25.62
Shares Outstanding 205.46M
Revenue 1.80B
EPS 1.59
Dividend (Yield %) 2.74779
Beta 0.22
Next Earnings Date Feb 21, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 27, 2023 40.65 0.34 0.84% 40.31 40.67 39.95
Jan 26, 2023 40.54 -0.66 -1.60% 41.20 41.43 40.45
Jan 25, 2023 40.84 -0.24 -0.58% 41.08 41.11 40.34
Jan 24, 2023 41.30 -0.17 -0.41% 41.47 41.61 41.06
Jan 23, 2023 41.32 -0.40 -0.96% 41.72 41.75 40.87
Jan 20, 2023 41.62 0.01 0.02% 41.61 42.13 41.50
Jan 19, 2023 41.64 -0.40 -0.95% 42.04 42.32 41.54
Jan 18, 2023 42.01 0.35 0.84% 41.66 42.31 41.44
Jan 17, 2023 41.83 1.40 3.46% 40.43 41.96 39.95
Jan 16, 2023 40.03 -0.12 -0.30% 40.15 40.31 39.92
Jan 13, 2023 40.05 0.66 1.68% 39.39 40.26 39.35
Jan 12, 2023 39.19 0.53 1.37% 38.66 39.23 38.59
Jan 11, 2023 38.78 -0.21 -0.54% 38.99 39.20 38.75
Jan 10, 2023 39.01 0.20 0.52% 38.81 39.27 38.77
Jan 9, 2023 39.21 0.53 1.37% 38.68 39.22 38.54
Jan 6, 2023 38.49 0.26 0.68% 38.23 38.59 38.09
Jan 5, 2023 38.32 -0.40 -1.03% 38.72 38.75 38.19
Jan 4, 2023 38.85 -0.11 -0.28% 38.96 39.27 38.72
Jan 3, 2023 38.78 -0.31 -0.79% 39.09 39.58 38.66
Jan 2, 2023 38.83 0.08 0.21% 38.75 39.04 38.66

Recordati SPA Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 1153.94 1288.12 1352.23 1481.85 1448.87 1580.07
Revenue 1153.94 1288.12 1352.23 1481.85 1448.87 1580.07
Cost of Revenue, Total 360.959 382.754 395.569 436.901 406.831 427.727
Gross Profit 792.983 905.369 956.666 1044.95 1042.04 1152.35
Total Operating Expense 826.519 881.631 910.016 1016.58 979.851 1089.88
Selling/General/Admin. Expenses, Total 369.219 396.375 401.219 445.586 421.857 480.889
Research & Development 83.71 100.256 67.093 77.081 146.236 166.138
Unusual Expense (Income) 12.631 2.246 3.535 0.264 4.927 14.478
Operating Income 327.423 406.492 442.219 465.266 469.016 490.19
Interest Income (Expense), Net Non-Operating -9.866 -17.148 -17.977 -20.616 -13.203 -26.718
Other, Net -0.275 -0.229 -6.307 -0.506 -0.157 -0.123
Net Income Before Taxes 317.282 389.115 417.935 444.144 455.656 463.349
Net Income After Taxes 237.431 288.799 312.422 368.866 355.027 385.966
Minority Interest -0.025 -0.037 -0.046 -0.041 -0.043 0
Net Income Before Extra. Items 237.406 288.762 312.376 368.825 354.984 385.966
Net Income 237.406 288.762 312.376 368.825 354.984 385.966
Income Available to Common Excl. Extra. Items 237.406 288.762 312.376 368.825 354.984 385.966
Income Available to Common Incl. Extra. Items 237.406 288.762 312.376 368.825 354.984 385.966
Dilution Adjustment 0.025
Diluted Net Income 237.431 288.762 312.376 368.825 354.984 385.966
Diluted Weighted Average Shares 209.19 209.096 209.087 209.084 209.06 209.082
Diluted EPS Excluding Extraordinary Items 1.135 1.381 1.494 1.764 1.698 1.846
Dividends per Share - Common Stock Primary Issue 0.7 0.85 0.92 1 1.05 1.1
Diluted Normalized EPS 1.18018 1.38897 1.50664 1.76505 1.7131 1.89642
Depreciation / Amortization 42.6 52.6
Other Operating Expenses, Total 4.15 0 0.652
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 384.838 385.997 385.354 423.885 419.381
Revenue 384.838 385.997 385.354 423.885 419.381
Cost of Revenue, Total 104.069 101.871 107.065 114.722 115.478
Gross Profit 280.769 284.126 278.289 309.163 303.903
Total Operating Expense 259.951 260.516 262.795 306.622 288.11
Selling/General/Admin. Expenses, Total 113.409 117.419 116.236 133.825 121.733
Research & Development 41.456 39.673 38.562 46.447 43.669
Unusual Expense (Income) 0.774 0.561 0.487 12.656 7.115
Other Operating Expenses, Total 0.243 0.992 0.445 -1.028 0.115
Operating Income 124.887 125.481 122.559 117.263 131.271
Interest Income (Expense), Net Non-Operating -8.883 -5.964 -7.313 -4.558 -6.926
Other, Net -0.01 -0.011 -0.01 -0.092 -0.027
Net Income Before Taxes 115.994 119.506 115.236 112.613 124.318
Net Income After Taxes 89.884 117.222 89.28 89.58 96.72
Minority Interest -0.012 -0.01 0.022 0
Net Income Before Extra. Items 89.872 117.212 89.302 89.58 96.72
Net Income 89.872 117.212 89.302 89.58 96.72
Income Available to Common Excl. Extra. Items 89.872 117.212 89.302 89.58 96.72
Income Available to Common Incl. Extra. Items 89.872 117.212 89.302 89.58 96.72
Diluted Net Income 89.872 117.212 89.302 89.58 96.72
Diluted Weighted Average Shares 209.005 209.347 209.142 208.836 209.351
Diluted EPS Excluding Extraordinary Items 0.43 0.55989 0.42699 0.42895 0.462
Dividends per Share - Common Stock Primary Issue 0 0.53 0 0.57 0
Diluted Normalized EPS 0.43 0.55874 0.42699 0.48058 0.48849
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 552.233 773.685 699.931 809.35 772.951 850.101
Cash and Short Term Investments 138.493 302.077 198.036 187.923 188.23 244.578
Cash 117.17 273.343 172.421 141.384 175.227 230.924
Cash & Equivalents 21.323 28.734 25.615 46.539 13.003 13.654
Total Receivables, Net 228.9 282.478 281.276 374.328 313.859 350.335
Accounts Receivable - Trade, Net 205.988 244.117 245.742 296.961 268.897 307.778
Total Inventory 158.8 179.1 206.084 226.885 251.252 228.732
Prepaid Expenses 8.062 6.205 8.121 10.265 12.574 15.307
Other Current Assets, Total 17.978 3.825 6.414 9.949 7.036 11.149
Total Assets 1560.74 2056.41 2161.26 2808.93 2711.65 2816.2
Property/Plant/Equipment, Total - Net 110.202 103.009 103.582 133.342 133.25 131.12
Property/Plant/Equipment, Total - Gross 374.684 376.699 387.858 437.716 453.036 462.825
Accumulated Depreciation, Total -264.482 -273.69 -284.276 -304.374 -319.786 -331.705
Goodwill, Net 556.566 539.871 577.786 577.973 562.116 553.209
Intangibles, Net 279.884 540.565 672.106 1161.76 1115.81 1138.79
Long Term Investments 19.199 24.171 20.773 38.566 45.581 34.124
Other Long Term Assets, Total 42.659 75.106 87.087 87.939 81.945 108.859
Total Current Liabilities 311.31 375.546 490.742 586.754 578.464 626.416
Accounts Payable 124.644 141.74 165.02 175.481 132.096 177.925
Accrued Expenses 42.807 43.68 42.289 45.267 39.649 56.191
Notes Payable/Short Term Debt 15.689 16.577 16.905 13.392 12.567 8.657
Current Port. of LT Debt/Capital Leases 40.428 51.71 130.583 149.817 270.254 223.061
Other Current Liabilities, Total 87.742 121.839 135.945 202.797 123.898 160.582
Total Liabilities 656.913 1029.32 1197.87 1610.35 1435.67 1434.57
Total Long Term Debt 293.644 612.462 640.647 937.344 778.238 760.473
Long Term Debt 293.644 612.462 640.647 937.344 760.587 745.382
Deferred Income Tax 27.659 17.554 43.486 43.172 41.219 26.675
Minority Interest 0.11 0.147 0.193 0.234 0.277 0
Other Liabilities, Total 24.19 23.608 22.804 42.849 37.473 21.01
Total Equity 903.83 1027.09 963.393 1198.58 1275.98 1381.62
Common Stock 26.141 26.141 26.141 26.141 26.141 26.141
Additional Paid-In Capital 83.719 83.719 83.719 83.719 83.719 83.719
Retained Earnings (Accumulated Deficit) 956.46 1064.13 1161.69 1334.42 1473.6 1612.81
Treasury Stock - Common -76.761 -17.029 -145.608 -93.48 -87.516 -126.981
Other Equity, Total -85.729 -129.871 -162.545 -152.223 -219.962 -214.06
Total Liabilities & Shareholders’ Equity 1560.74 2056.41 2161.26 2808.93 2711.65 2816.2
Total Common Shares Outstanding 205.234 208.262 204.379 204.959 206.296 205.911
Capital Lease Obligations 17.651 15.091
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 861.321 907.382 958.115 850.101 961.621
Cash and Short Term Investments 250.085 271.869 341.926 244.578 261.43
Cash & Equivalents 250.085 271.869 341.926 244.578 261.43
Total Receivables, Net 343.118 357.259 345.649 352.658 407.68
Accounts Receivable - Trade, Net 307.91 304.542 300.769 307.778 367.012
Total Inventory 243.684 257 244.501 228.732 256.489
Other Current Assets, Total 24.434 9.067 26.039 11.149 36.022
Total Assets 2837.47 2875.92 2929.54 2816.2 3642.95
Property/Plant/Equipment, Total - Net 131.384 130.9 132.992 131.12 129.207
Property/Plant/Equipment, Total - Gross 455.542 458.108 464.546 462.825 464.469
Accumulated Depreciation, Total -324.158 -327.208 -331.554 -331.705 -335.262
Goodwill, Net 560.466 559.899 560.309 553.209 1125.12
Intangibles, Net 1143.84 1132.93 1128.04 1138.79 1292.75
Long Term Investments 47.405 39.672 41.963 34.124 23.34
Other Long Term Assets, Total 93.055 105.135 108.13 108.859 110.922
Total Current Liabilities 628.61 586.368 610.638 626.416 725.019
Accounts Payable 145.065 160.355 166.917 177.925 194.998
Notes Payable/Short Term Debt 35.997 29.106 13.478 8.657 15.022
Current Port. of LT Debt/Capital Leases 275.06 222.805 228.168 223.061 252.279
Other Current Liabilities, Total 172.488 174.102 202.075 216.773 262.72
Total Liabilities 1508.69 1547.83 1484.48 1434.57 2193.52
Total Long Term Debt 800.325 895.648 824.701 760.473 1403.58
Long Term Debt 800.325 879.552 808.965 745.382 1389.77
Deferred Income Tax 41.11 27.17 27.787 26.675 26.909
Minority Interest 0.289 0.299 0 0 0
Other Liabilities, Total 38.354 38.343 21.351 21.01 38.015
Total Equity 1328.78 1328.09 1445.07 1381.62 1449.43
Common Stock 26.141 26.141 26.141 26.141 26.141
Additional Paid-In Capital 83.719 83.719 83.719 83.719 83.719
Retained Earnings (Accumulated Deficit) 1562.21 1552.6 1640.89 1612.81 1699.78
Treasury Stock - Common -126.637 -115.257 -98.924 -126.981 -144.381
Other Equity, Total -216.649 -219.116 -206.753 -214.06 -215.826
Total Liabilities & Shareholders’ Equity 2837.47 2875.92 2929.54 2816.2 3642.95
Total Common Shares Outstanding 205.479 205.909 206.365 205.911 205.587
Prepaid Expenses 12.187 12.984
Capital Lease Obligations 16.096 15.736 15.091 13.81
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 237.431 288.799 312.422 368.866 355.027 385.966
Cash From Operating Activities 255.436 272.711 357.838 318.7 403.575 492.129
Cash From Operating Activities 12.466 14.186 13.901 25.17 25.355 25.294
Amortization 25.466 33.967 42.959 53.078 68.317 72.291
Deferred Taxes -5.637 -32.422 -6.637
Non-Cash Items 6.919 -11.407 4.697 102.747 124.979 113.194
Changes in Working Capital -21.209 -20.412 -9.504 -231.161 -170.103 -104.616
Cash From Investing Activities -158.489 -321.188 -231.778 -441.209 -131.555 -87.499
Capital Expenditures -19.669 -14.588 -19.362 -443.288 -131.678 -87.36
Other Investing Cash Flow Items, Total -138.82 -306.6 -212.416 2.079 0.123 -0.139
Cash From Financing Activities -189.819 224.656 -224.688 109.526 -264.288 -355.943
Financing Cash Flow Items -1.679 3.716 0.439 -2.19 1.74
Total Cash Dividends Paid -133.73 -159.607 -178.887 -190.916 -212.718 -216.742
Issuance (Retirement) of Stock, Net -48.886 30.267 -149.552 26.187 -12.17 -59.308
Issuance (Retirement) of Debt, Net -5.524 350.28 103.312 276.445 -41.14 -79.893
Net Change in Cash -92.872 162.696 -104.369 -10.113 0.307 56.348
Foreign Exchange Effects -13.483 -5.741 2.87 -7.425 7.661
Cash Taxes Paid 140.14 65.272 91.646
Cash Interest Paid 17.597 18.699 18.279
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 89.884 207.106 296.386 385.966 96.72
Cash From Operating Activities 114.135 213.826 368.622 492.129 113.431
Cash From Operating Activities 6.311 12.633 18.928 25.294 6.016
Amortization 18.049 35.873 53.968 72.291 18.635
Non-Cash Items 31.74 40.95 73.508 113.194 35.714
Cash Taxes Paid 6.302 46.563 61.599 91.646 10.653
Cash Interest Paid 2.243 9.147 11.476 18.279 2.344
Changes in Working Capital -31.849 -82.736 -74.168 -104.616 -43.654
Cash From Investing Activities -57.132 -66.56 -76.89 -87.499 -722.27
Capital Expenditures -57.317 -66.718 -76.744 -87.36 -15.599
Other Investing Cash Flow Items, Total 0.185 0.158 -0.146 -0.139 -706.671
Cash From Financing Activities 1.754 -66.585 -143.698 -355.943 571.438
Total Cash Dividends Paid -0.74 -108.699 -109.389 -216.742 -6.219
Issuance (Retirement) of Stock, Net -43.227 -40.458 -29.028 -59.308 -18.383
Issuance (Retirement) of Debt, Net 45.721 82.572 -5.281 -79.893 596.04
Foreign Exchange Effects 3.098 2.958 5.662 7.661 1.018
Net Change in Cash 61.855 83.639 153.696 56.348 -36.383
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fimei Finanziaria Industriale Mobiliare Ed Immobiliare SpA Holding Company 51.82 108368656 0 2023-01-04 LOW
Mawer Investment Management Ltd. Investment Advisor 4.997 10449984 -43916 2022-12-07 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.402 7114438 0 2023-01-04 LOW
FMR Investment Management (U.K.) Limited Investment Advisor 1.7918 3747134 181356 2022-11-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.3647 2853934 21111 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.2497 2613375 -78568 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.8274 1730394 49494 2021-12-31 LOW
La Financière de l'Echiquier Investment Advisor 0.618 1292377 40 2022-11-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5425 1134566 211 2022-12-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.451 943207 -6025 2022-12-31 LOW
Manulife Investment Management (North America) Limited Investment Advisor 0.4195 877356 17787 2022-11-30 LOW
Invesco Advisers, Inc. Investment Advisor 0.3733 780646 0 2022-11-30 LOW
California Public Employees' Retirement System Pension Fund 0.371 775787 -99342 2021-06-30 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.3659 765091 519 2022-12-31 HIGH
State Street Global Advisors (UK) Ltd. Investment Advisor/Hedge Fund 0.3616 756114 -23040 2022-12-31 LOW
TD Asset Management Inc. Investment Advisor 0.3407 712591 1039 2022-12-31 LOW
Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 0.3311 692330 575 2022-11-30 LOW
Epoch Investment Partners, Inc. Investment Advisor 0.331 692301 -46 2022-12-31 LOW
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.3033 634283 0 2022-11-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.2699 564451 -101 2022-12-31 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+485000+

Traders

65000+

Active clients monthly

$48000000+

Monthly investing volume

$28000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Profit/Loss

Recordati Company profile

About Recordati Industria Chimica e Farma SpA

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Recordati Industria Chimica e Farma SpA revenues increased 9% to EUR1.58B. Net income increased 9% to EUR386M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from EUR1.05 to EUR1.10. Basic Earnings per Share excluding Extraordinary Items increased from EUR1.73 to EUR1.87.

Industry: Pharmaceuticals (NEC)

Via M. Civitali, 1
MILANO
MILANO 20148
IT

Income Statement

  • Annual
  • Quarterly

News

Global Currencies.

FX Weekly Outlook: USD, GBP/USD, EUR/USD Analysis

USD, GBP/USD, EUR/USD forecasts for the week ahead.

16:33, 27 January 2023
Businessman representing recessionary, stagflation or inflation economies with graphs of the stock market as a concept of raw material. Financial world crisis concept.

WTI, Gold, Silver – commodities weekly forecast for the week ahead

Strength to strength in the commodity space, however, topside exhaustion begins to creep in

13:53, 27 January 2023
Rising stock market chart on a trading board background.

S&P 500, Nasdaq, DAX 40, Hang Seng technical update

Can the S&P 500 hold above its 2022 descending trend line?

12:44, 26 January 2023
photo illustration an Amazon logo seen displayed on a smartphone.

Amazon Q4 earnings: online retailer to feel the pinch of higher costs and slowing consumer spending

AMZN Q4 earnings preview and technical analysis

09:59, 25 January 2023
Bank of Canada outlook

Canadian Dollar Forecast: Bank of Canada Heading Towards a Final Rate Hike

Bank of Canada expected to hike 25bps at its upcoming meeting. Focus on whether the BoC announces a pause going forward.

15:49, 24 January 2023

People also watch

US100

12,164.80 Price
+1.340% 1D Chg, %
Long position overnight fee -0.0179%
Short position overnight fee 0.0070%
Overnight fee time 22:00 (UTC)
Spread 3.0

Natural Gas

2.86 Price
+0.740% 1D Chg, %
Long position overnight fee -0.0485%
Short position overnight fee 0.0282%
Overnight fee time 22:00 (UTC)
Spread 0.005

ETH/USD

1,646.11 Price
+4.660% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 5.50

BTC/USD

23,798.70 Price
+3.120% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 66.00

Market analysis

A large Amazon logo displayed on the side of an Amazon building

Amazon stock forecast: Where next for AMZN amid massive layoffs?

17:55, 23 January 2023
Australian dollar bills

Australian dollar forecast: Will AUD outperform in 2023?

17:49, 20 January 2023
Dogecoin token on mobile phone screen

Dogecoin price prediction: DOGE to the moon?

17:43, 20 January 2023

Still looking for a broker you can trust?

Join the 480.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading